Page last updated: 2024-08-24

remifentanil and Ischemia

remifentanil has been researched along with Ischemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, X; Pan, Z; Su, D; Tian, J; Wang, X; Yang, Z; Zheng, B1
Aktas, S; Atalay, YO; Kucukodaci, Z; Ozakpinar, OB; Sahin, S1
Chen, YL; Chen, ZC; Lv, Y; Shen, X; Zhao, G1

Other Studies

3 other study(ies) available for remifentanil and Ischemia

ArticleYear
Remifentanil Ameliorates Liver Ischemia-Reperfusion Injury Through Inhibition of Interleukin-18 Signaling.
    Transplantation, 2015, Volume: 99, Issue:10

    Topics: Analgesics, Opioid; Animals; Gene Expression Regulation; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-18; Ischemia; Liver; Male; Naloxone; Neutrophils; Peroxidase; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; Signal Transduction; Transaminases

2015
Remifentanil protects uterus against ischemia-reperfusion injury in rats.
    Acta cirurgica brasileira, 2015, Volume: 30, Issue:11

    Topics: Analgesics, Opioid; Animals; Antioxidants; Catalase; Female; Ischemia; Malondialdehyde; Piperidines; Random Allocation; Rats, Wistar; Remifentanil; Reperfusion Injury; Reproducibility of Results; Superoxide Dismutase; Time Factors; Uterus

2015
[Protective effect of remifentanil preconditioning against hepatic ischemia-reperfusion injury in rats: role of p38 mitogen-activated protein kinases].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2011, Volume: 31, Issue:12

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Imidazoles; Interleukin-1beta; Ischemia; Ischemic Preconditioning; Liver; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Remifentanil; Reperfusion Injury; Tumor Necrosis Factor-alpha

2011